DOSEF (Doseology Sciences) ROCE %: -139.23% (As of Mar. 2026)


DOSEF Doseology Sciences Inc DOSEF
33 GF Score
Price $0.11
GF Value $0.29
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is Doseology Sciences ROCE %?

Doseology Sciences DOSEF -16.16% 33 ROCE % is -139.23% as of Mar. 2026. GuruFocus rates DOSEF with a GF Score™ of 33/100 and a GF Value™ of $0.29 (Possible Value Trap). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Doseology Sciences's annualized ROCE % for the quarter that ended in Mar. 2026 was -139.23%.

Doseology Sciences  (OTCPK:DOSEF) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Doseology Sciences ROCE % Related Terms

Doseology Sciences ROCE % Historical Data

* Premium members only.

The historical data trend for Doseology Sciences's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Doseology Sciences ROCE % Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
ROCE %
Get a 7-Day Free Trial -74.19 -52.96 -68.47 -31.94 -39.05

Doseology Sciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -37.41 -88.50 -46.39 -91.70 -139.23
DOSEF
33GF Score
Doseology Sciences Inc DOSEF
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Doseology Sciences ROCE % Calculation

Doseology Sciences's annualized ROCE % for the fiscal year that ended in Jun. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jun. 2025 )  (A: Jun. 2024 )(A: Jun. 2025 )
=-0.345/( ( (0.804 - 0.06) + (1.092 - 0.069) )/ 2 )
=-0.345/( (0.744+1.023)/ 2 )
=-0.345/0.8835
=-39.05 %

Doseology Sciences's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Dec. 2025 )(Q: Mar. 2026 )
=-1.228/( ( (1.013 - 0.051) + (0.861 - 0.059) )/ 2 )
=-1.228/( ( 0.962 + 0.802 )/ 2 )
=-1.228/0.882
=-139.23 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -139.23% mean?
Doseology Sciences (DOSEF) has a ROCE % of -139.23% as of Mar. 2026.
Is Doseology Sciences' ROCE % too high?
Doseology Sciences' current ROCE % is -139.23%. Overall, Doseology Sciences has a GF Score™ of 33/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Doseology Sciences' ROCE % compare to VRTX and REGN?
Doseology Sciences' ROCE % of -139.23% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. Doseology Sciences's current ROCE % is -139.23%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Doseology Sciences stock overvalued right now?
Based on GuruFocus' analysis, Doseology Sciences (DOSEF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.29, compared to a current price of $0.11 — trading 61.3% below its estimated fair value. The current ROCE % is -139.23%. Doseology Sciences' overall GF Score™ is 33/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Doseology Sciences (DOSEF), the current ROCE % is -139.23% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Doseology Sciences (DOSEF) Overvalued in 2026?

Based on GuruFocus' analysis, Doseology Sciences stock appears to be undervalued. The current stock price of $0.11 is trading 61.3% below its estimated GF Value™ of $0.29. GuruFocus considers Doseology Sciences to be Possible Value Trap.

Key valuation signals for DOSEF:

  • ROCE %: -139.23%
  • GF Value™: $0.29 vs. price of $0.11 (61.3% below fair value)
  • GF Score™: 33/100 with 4 warning signs

No single metric tells the full story. See the DOSEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Doseology Sciences Business Description

Other Exchanges MOOD:Canada
Address 9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. It offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.
33GF Score

Get the complete analysis for DOSEF

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.11
Price
$0.29
GF Value